Differential effect of phosphodiesterase 4 inhibitors on the proliferation of human peripheral blood mononuclear cells from normals and subjects with atopic dermatitis

British Journal of Pharmacology

Volumn 116, Issue 8, 1995, Pages 3169-3174

  Banner, Katharine H ^a   Roberts, Nerys M ^b   Page, Clive P ^a  

^a KING'S COLLEGE LONDON   (United Kingdom)

^b CHELSEA AND WESTMINSTER HOSPITAL   (United Kingdom)

Author keywords

atopy; Isoenzyme selective PDE inhibitors; peripheral blood mononuclear cells

Indexed keywords

4 (3 BUTOXY 4 METHOXYBENZYL) 2 IMIDAZOLIDINONE; BENZAFENTRINE; DENBUFYLLINE; PHOSPHODIESTERASE; PHOSPHODIESTERASE INHIBITOR; PHYTOHEMAGGLUTININ; ROLIPRAM; SIGUAZODAN; THYMIDINE; VINPOCETINE; ZAPRINAST; ZARDAVERINE;

ARTICLE; ATOPIC DERMATITIS; CELL PROLIFERATION; CONCENTRATION RESPONSE; CONTROLLED STUDY; DNA SYNTHESIS; DRUG EFFECT; ENZYME INHIBITION; HUMAN; HUMAN CELL; MONONUCLEAR CELL; PRIORITY JOURNAL; VENOUS BLOOD;

3',5'-CYCLIC-NUCLEOTIDE PHOSPHODIESTERASE; CELL DIVISION; HUMANS; HYPERSENSITIVITY, IMMEDIATE; LEUKOCYTES, MONONUCLEAR; MITOGENS; PHOSPHODIESTERASE INHIBITORS; PHOSPHORIC DIESTER HYDROLASES;

EID: 0029560498     PISSN: 00071188     EISSN: 14765381     Source Type: Journal    
DOI: 10.1111/j.1476-5381.1995.tb15120.x     Document Type: Article

References (41)

1. Inhibition of interleukin 2 production is mediated by a cyclic adenosine monophosphate (cAMP)‐dependent pathway
2. T‐lymphocytes and activated eosinophils in airway mucosa in fatal asthma and cystic fibrosis
3. Effect of type III and IV isozyme selective phosphodiesterase (PDE) inhibitors on proliferation of human peripheral blood mononuclear cells
4. Prostaglandin E2 inhibits production of Th1 lymphokines but not of Th2 lymphokines
5. Effects of cholera toxin on in vitro models of immediate and delayed hypersensitivity: further evidence for the role of cAMP
6. Increased histamine release associated with elevated cAMP phosphodiesterase activity in atopic dermatitis
7. Immunochemical characterization of the distinct monocyte cyclic AMP phosphodiesterase from patients with atopic dermatitis
8. Differential inhibitor effects on cyclic adenosine monophosphate‐phosphodiesterase isoforms in atopic and normal leukocytes
9. Intracellular events during lymphocyte activation
10. Phosphodiesterase inhibition of RO 20–1724 reduces hyper‐IgE synthesis by atopic dermatitis cells in vitro
11. Theophylline suppresses human alveolar macrophage respiratory burst through phosphodiesterase inhibition
12. Theophylline‐induced alterations in cellular immunity in asthmatic patients
13. Could isozyme‐selective phosphodiesterase inhibitors render bronchodilator therapy redundant in the treatment of bronchial asthma?
14. Current status of cyclic nucleotide phosphodiesterase isoenzymes
15. Inhibition of CD4 and CD8 T‐lymphocyte proliferation and cytokine secretion by isoenzyme selective phosphodiesterase (PDE) inhibitors: correlation with intracellular cyclic AMP concentrations
16. In leukocyte sensitivity to PDE inhibitors in atopic dermatitis: tachyphylaxis after theophylline therapy
17. Elevated leukocyte cyclic AMP‐phosphodiesterase in atopic disease: a possible mechanism for cyclic AMP‐agonist hyporesponsiveness
18. Transmembrane signals in the activation of T‐lymphocytes by mitogenic agents
19. Monocyte localization of elevated cAMP phosphodiesterase activity in atopic dermatitis
20. Modulation of T‐lymphocyte activity in atopic asthmatics by low dose theophylline therapy
21. The adenylate cyclase‐cAMP‐protein kinase A pathway and regulation of the immune response
22. Effect of theophylline on the proportion and function of T suppressor cells in asthmatic children
23. Increased cyclic adenosine monophosphate levels block progression but not initiation of human T cell proliferation
24. Regulation of interleukin 2 synthesis by cAMP in human T cells
25. Early increase in lymphocyte cyclic nucleotide phosphodiesterase activity upon mitogenic activation of human peripheral blood mononuclear cells
26. Asthma‐something old, something new
27. Inhibitors of cyclic nucleotide phosphodiesterase isoenzymes‐their potential utility in the therapy of asthma
28. Selective suppression by adherent cells, prostaglandin, and cyclic AMP analogues of blastogenesis induced by different mitogens
29. Effects of dipyridamole on human blood lymphocytes
30. Multiple high‐affinity cAMP‐phosphodiesterases in human T‐lymphocytes
31. Elevated cyclic adenosine monophosphate phosphodiesterase activity in peripheral blood mononuclear leucocytes from children with atopic dermatitis
32. Effect of selective phosphodiesterase (PDE) inhibitors on activation of human macrophages and lymphocytes
33. Induction of suppressor T cells in asthmatic children by theophylline treatment
34. Interleukin 2 regulates its own receptors
35. Characterization of guinea pig eosinophil phosphodiesterase activity
36. Cyclic AMP phosphodiesterase in human lymphocytes and lymphoblasts
37. Cyclic adenosine 3′: 5′‐ monophosphate phosphodiesterase: distinct forms in human lymphocytes and monocytes
38. Interleukin‐2‐dependent autocrine proliferation in T cell development
39. Phosphodiesterase inhibitors: new opportunities for the treatment of asthma
40. Theophylline‐ An immunomodulatory role in asthma?